Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Maze Therapeutics Inc (MAZE)

Maze Therapeutics Inc (MAZE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Maze Therapeutics Inc 171 OYSTER POINT BOULEVARD SUITE 300 SAN FRANCISCO CA 94080 USA

www.mazetx.com Employees: 125 P: 650-850-5070

Sector:

Medical

Description:

Maze Therapeutics Inc. is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases. Maze Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 2,007,043
Enterprise Value, $K 2,318,323
Shares Outstanding, K 48,119
Annual Sales, $ 167,500 K
Annual Net Income, $ 52,230 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -30,090 K
EBIT, $ -134,570 K
EBITDA, $ -131,270 K
Float, K 48,119
% Float 100.00%
Short Interest 2,221
Short Float 4.62%
Short Volume Ratio 0.73

Growth:

1-Year Return 161.50%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.66 on 11/06/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -20.90
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year 85.70%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MAZE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -90.66%
Return-on-Assets % -43.45%
Profit Margin % 31.18%
Debt/Equity 0.00
Price/Sales 11.98
Price/Cash Flow 272.45
Price/Book 5.28
Book Value/Share 7.89
Interest Coverage 3.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar